Advanced personalized PCa treatment modalities such as metastasis-directedradiotherapy and PSMA radioligand therapy are highly dependent on PSMA PET/CTreported findings.5, –7 Therefore,accurate image interpretation plus complete and uniform reporting of findings onPSMA PET/CT are mandatory and indispensable. The gene discussed is FOLH1; the disease is posterior cortical atrophy.